These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8410134)

  • 1. Splenectomy and risk of secondary leukemia.
    Meadows AT; Robison L
    J Clin Oncol; 1993 Oct; 11(10):2054. PubMed ID: 8410134
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International note: second malignant neoplasms in children: a multicenter study of the Polish Pediatric Leukemia/Lymphoma Group.
    Kowalczyk JR; Nurzyńska J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Kołecki P; Matysiak M; Pawelec K;
    Med Pediatr Oncol; 2002 Jun; 38(6):421-3. PubMed ID: 11984804
    [No Abstract]   [Full Text] [Related]  

  • 5. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
    Schellong G; Riepenhausen M
    Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenectomy and second malignancies in patients with Hodgkin lymphoma.
    Kooistra HA; Kluin-Nelemans HC; van Imhoff GW; van Dijk BA; de Bock GH; van der Kaaij MA
    Leuk Lymphoma; 2015 Jan; 56(1):230-1. PubMed ID: 24707939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of infections following splenectomy, especially in patients with malignant lymphoma].
    Roux A; Fischer J; Dennhardt HH; Gamm H; Preiss J; Zeile G
    Verh Dtsch Ges Inn Med; 1974; 80():1513-5. PubMed ID: 4454470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term toxicity of curative lymphoma therapy].
    Gassmann W; Slanina J
    Internist (Berl); 1993 Feb; 34(2):161-9. PubMed ID: 8454430
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the risk of second malignant tumors in children with Hodgkin's disease.
    Donaldson SS; O'Brien MM
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):4-5. PubMed ID: 18722256
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia occurring as a second malignancy: report of a case and review of literature.
    Geetha N; SreedeviAmma N; Kusumakumary P; Lali VS; Nair MK
    Pediatr Hematol Oncol; 1999; 16(3):267-70. PubMed ID: 10326227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insufficient understanding of second tumors after childhood neoplasms in Switzerland].
    Konrad D; Niggli E; Plüss HJ
    Schweiz Med Wochenschr; 1998 Mar; 128(13):486-90. PubMed ID: 9583099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Splenectomy in lymphogranulomatosis].
    Simbirtseva LP
    Vopr Onkol; 1980; 26(3):97-102. PubMed ID: 6966108
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies.
    Park S; Brice P; Noguerra ME; Simon D; Rousselot P; Kerneis Y; Morel P; Marolleau JP; Gisselbrecht C
    Bone Marrow Transplant; 2000 Aug; 26(3):321-6. PubMed ID: 10967573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.